Characteristic | Total (N = 1918) | Delay in first adjuvant therapya | Delay in radiation therapy >90 days | Delay in chemotherapy >60 days | |||
---|---|---|---|---|---|---|---|
n (%) | n (%) | p | n (%) | p | n (%) | p | |
Ethnicity | |||||||
NZ European | 1564 (81.5) | 478 (30.6) | 261 (30.6) | 217 (30.5) | |||
Māori | 266 (13.9) | 101 (38.0) | 0.022 | 45 (39.8) | 0.045 | 57 (37.3) | 0.103 |
Pacific | 38 (2.0) | 19 (50.0) | 0.013 | 6 (54.5) | 0.101 | 13 (48.1) | 0.057 |
Other | 50 (2.6) | 21 (42.0) | 0.112 | 7 (35.0) | 0.676 | 14 (46.7) | 0.065 |
Age (years) | 0.846 | 0.704 | 0.091 | ||||
<40 | 117 (6.1) | 38 (32.5) | 9 (40.9) | 29 (30.5) | |||
40-49 | 433 (22.6) | 130 (30.0) | 43 (32.8) | 87 (28.8) | |||
50-59 | 583 (30.4) | 193 (33.1) | 89 (34.2) | 104 (32.2) | |||
60-69 | 494 (25.8) | 165 (33.4) | 94 (29.2) | 71 (41.3) | |||
70-79 | 212 (11.1) | 70 (33.0) | 60 (33.0) | 10 (33.3) | |||
80+ | 79 (4.1) | 23 (29.1) | 23 (29.1) | 0 | |||
Stage at diagnosis | <0.001 | <0.001 | 0.048 | ||||
I | 800 (41.7) | 228 (28.5) | 176 (27.0) | 52 (35.4) | |||
II | 772 (40.3) | 291 (37.7) | 112 (43.1) | 179 (35.0) | |||
III | 346 (18.0) | 100 (28.9) | 30 (36.1) | 70 (26.6) | |||
Year of diagnosis | <0.001 | <0.001 | <0.001 | ||||
1999-2002 | 393 (20.5) | 166 (42.2) | 105 (62.5) | 61 (27.1) | |||
2003-2006 | 579 (30.2) | 181 (31.3) | 107 (35.9) | 74 (26.3) | |||
2007-2009 | 452 (23.6) | 146 (32.3) | 50 (20.0) | 96 (47.5) | |||
2010-2012 | 494 (25.8) | 126 (25.5) | 56 (20.0) | 70 (32.7) | |||
Screening status | 0.162 | 0.005 | 0.247 | ||||
Non-screen | 1110 (57.9) | 372 (33.5) | 171 (36.3) | 201 (31.5) | |||
Screen detected | 808 (42.1) | 247 (30.6) | 147(28.0) | 100 (35.3) | |||
Deprivation | 0.257 | 0.795 | 0.147 | ||||
Dep 1-2 | 213 (11.1) | 55 (25.8) | 29 (28.7) | 26 (23.2) | |||
Dep 3-4 | 206 (10.7) | 66 (32.0) | 36 (34.3) | 30 (29.7) | |||
Dep 5-6 | 487 (25.4) | 161 (33.1) | 75 (29.8) | 86 (36.6) | |||
Dep 7-8 | 532 (27.7) | 174 (32.7) | 98 (32.7) | 76 (32.8) | |||
Dep 9-10 | 480 (25.0) | 163 (34.0) | 80 (33.6) | 83 (34.3) | |||
Primary surgery | 0.913 | 0.014 | 0.058 | ||||
BCS | 1318 (68.7) | 425 (32.2) | 260 (30.4) | 165 (35.6) | |||
Mastectomy | 600 (31.3) | 194 (32.3) | 58 (40.8) | 136 (29.7) | |||
Re-excision | <0.001 | <0.001 | 0.002 | ||||
No | 1659 (86.5) | 491 (29.6) | 250 (28.6) | 241 (30.7) | |||
Yes | 259 (13.5) | 128 (49.4) | 68 (55.3) | 60(44.1) | |||
Distance from hospital | 0.019 | 0.021 | 0.540 | ||||
<10 km | 630 (32.8) | 192 (30.5) | 94 (28.1) | 98 (33.1) | |||
10-50 km | 740 (38.6) | 221 (29.9) | 107 (29.2) | 114 (30.5) | |||
50-100 km | 462 (24.1) | 169 (36.6) | 100 (38.9) | 69 (33.7) | |||
>100 km | 86 (4.5) | 37 (43.0) | 17 (43.6) | 20 (42.6) | |||
Surgical facility type | <0.001 | 0.009 | 0.001 | ||||
Private | 632 (33.0) | 163 (25.8) | 73 (25.8) | 90 (25.8) | |||
Public | 1286 (67.0) | 456 (35.5) | 245 (34.4) | 211 (36.8) | |||
Charlson score | 0.175 | 0.434 | 0.520 | ||||
0 | 1677 (87.4) | 534 (31.8) | 265 (31.7) | 269 (32.0) | |||
1+ | 241 (12.6) | 85 (35.3) | 53 (33.3) | 32 (39.0) |